Details of the Drug

General Information of Drug (ID: DMV574J)

Drug Name

CSL312

Synonyms

Garadacimab

Indication

Disease Entry	ICD 11	Status	REF
Hereditary angioedema	4A00.14	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04656418) CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of CSL Behring.